← SynDRA
NAPABUCASIN
SynDRA canonical compound SYN0002825 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | STAT3 |
| Mechanism of action | STAT inhibitor |
All known targets
Mechanisms of action (all sources)
- STAT INHIBITOR
- STAT3 INHIBITOR
Cross-references
Synonyms
- Napabucasine
- Napabucasina
- 2-acetylfuranonaphthoquinone
- 2-acetylfuro-1,4-naphthoquinone
- BBI-608
- BBI608
- UNII-Z1HHM49K7O
- 2-acetylnaphtho[2,3-b]furan-4,9-dione
- Z1HHM49K7O
- 2-Acetylnaphtho(2,3-b)furan-4,9-dione
- 2-Acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione
- Napabucasin [USAN:INN]
- Napabucasin (BBI608)
- 2-Acetylfuranonaphthoquinone
- CHEMBL64130
- Napabucasin (JAN/USAN/INN)
- SCHEMBL1883845
- Napabucasin - BBI 608/ FNQ
- 2-Acetylfuro-1,4-naphthoquinone
- DPHUWDIXHNQOSY-UHFFFAOYSA-N
- MolPort-039-101-321
- EX-A1314
- ZINC13306865
- s7977
- AKOS027470201
- DB12155
- CS-1747
- ACN-053294
- HY-13919
- 2-acetylbenzo[f][1]benzofuran-4,9-dione
- BBI 608
- FNQ
- Napabucasin; BBI608
- NAPABUCASIN [INN]
- NAPABUCASIN [JAN]
- NAPABUCASIN [USAN]
- NAPABUCASIN [WHO-DD]
- GTPL11358
- AMY27812
Look up NAPABUCASIN in the interactive SynDRA portal →